3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Breast
1
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Solid Tumor
2
Lymphatic Metastasis
2
Prostatic Neoplasms
1
Osteoporosis
1
Melanoma
1
Immunoglobulin Light-chain Amyloidosis
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Amyloidosis
1
Interventions
Indocyanine Green
7
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Lymph Node Excision
4
Cisplatin
4
Surgical Procedures, Operative
3
Specimen Handling
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
gewf solution
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Lymphatic Metastasis
×
Technetium
×
Clear all
NCT07146295
2026-01-12
INFINITE
St. Antonius Hospital
Phase NA
Recruiting
1,760 enrolled
NCT04233476
2024-07-01
TRIIL
RDO Pharm.
Phase 3
Completed
409 enrolled